Loading...

ZLAB ZAI LAB LTD Investments/Divestments 8-K Filing

Z LB

ZLB

ZAI LAB LTD

(ZLAB)

2023 8-K

Financial Results Announced

Q3 Financial Results

Debt Facility Agreement

Earnings Releases

Financial Statements

Financial Results

Debt Facility Agreement

Public Offering

Risk Factors Update

Q3 Financial Results

Earnings Reports

Debt Facility with China Me...

Equity Incentive Plan Approved

Management Changes

Financial Results Announcement

Financial Results Announcement

Debt Arrangements with Chin...

Financial Results Announcement

Earnings Reports

Annual General Meeting

Clinical Trial Results

Financial Results Announcement

Trading Suspension

Financial Results Announcement

Appointment of Independent ...

Other Special Situation

External Links:

Zai Lab Ltd announced that China's National Medical Products Administration has approved the Biologics License Application for VYVGART, a treatment for adult patients with generalized myasthenia gravis.

AI Assistant

ZAI LAB LTD

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.